Literature DB >> 9284835

Frequent p16INK4 (MTS1) gene inactivation in testicular germ cell tumors.

P Chaubert1, L Guillou, A M Kurt, M M Bertholet, G Metthez, H J Leisinger, F Bosman, P Shaw.   

Abstract

The molecular mechanisms responsible for the development of testicular germ cell tumors (GCTs) have not as yet been elucidated. The aim of the present study was to determine whether genetic alterations of p16INK4 (MTS1) and/or cyclin-dependent kinase 4 (CDK4) occur in the genesis of these tumors. We have analyzed these two genes in 29 testicular GCTs, seminomas, and nonseminomas. None of the tumors showed either p16INK4 or CDK4 mutations. Only 1 of the 29 GCTs displayed loss of heterozygosity of the p16INK4 gene. No homozygous deletions of p16INK4 were detected. Evidence of hypermethylation of p16INK4 exon 1, however, was demonstrated in 13 of the 26 (50%) GCTs analyzed. Tumor samples having exon 1 of p16INK4 methylated expressed significantly lower levels of p16INK4 mRNA, as analyzed by reverse transcriptase polymerase chain reaction. These results suggest that p16INK4 inactivation plays a role in the genesis of GCTs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9284835      PMCID: PMC1857830     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

1.  p16 gene in uncultured tumours.

Authors:  C H Spruck; M Gonzalez-Zulueta; A Shibata; A R Simoneau; M F Lin; F Gonzales; Y C Tsai; P A Jones
Journal:  Nature       Date:  1994-07-21       Impact factor: 49.962

2.  Germline p16 mutations in familial melanoma.

Authors:  C J Hussussian; J P Struewing; A M Goldstein; P A Higgins; D S Ally; M D Sheahan; W H Clark; M A Tucker; N C Dracopoli
Journal:  Nat Genet       Date:  1994-09       Impact factor: 38.330

3.  Informative MspI polymorphism adjacent to exon 3 of the p16INK4 (MTS1) gene.

Authors:  P Chaubert; P Shaw; N Pillet
Journal:  Mol Cell Probes       Date:  1996-12       Impact factor: 2.365

4.  Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias.

Authors:  J Hebert; J M Cayuela; J Berkeley; F Sigaux
Journal:  Blood       Date:  1994-12-15       Impact factor: 22.113

5.  The MTS1 gene is frequently mutated in primary human esophageal tumors.

Authors:  X Zhou; L Tarmin; J Yin; H Y Jiang; H Suzuki; M G Rhyu; J M Abraham; S J Meltzer
Journal:  Oncogene       Date:  1994-12       Impact factor: 9.867

6.  A cell cycle regulator potentially involved in genesis of many tumor types.

Authors:  A Kamb; N A Gruis; J Weaver-Feldhaus; Q Liu; K Harshman; S V Tavtigian; E Stockert; R S Day; B E Johnson; M H Skolnick
Journal:  Science       Date:  1994-04-15       Impact factor: 47.728

7.  Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma.

Authors:  C Caldas; S A Hahn; L T da Costa; M S Redston; M Schutte; A B Seymour; C L Weinstein; R H Hruban; C J Yeo; S E Kern
Journal:  Nat Genet       Date:  1994-09       Impact factor: 38.330

8.  Mutation rate of the CDKN2 gene in malignant gliomas.

Authors:  C Giani; G Finocchiaro
Journal:  Cancer Res       Date:  1994-12-15       Impact factor: 12.701

9.  Deletion of p16 and p15 genes in brain tumors.

Authors:  J Jen; J W Harper; S H Bigner; D D Bigner; N Papadopoulos; S Markowitz; J K Willson; K W Kinzler; B Vogelstein
Journal:  Cancer Res       Date:  1994-12-15       Impact factor: 12.701

10.  CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.

Authors:  E E Schmidt; K Ichimura; G Reifenberger; V P Collins
Journal:  Cancer Res       Date:  1994-12-15       Impact factor: 12.701

View more
  5 in total

Review 1.  Molecular genetics of pineal region neoplasms.

Authors:  M D Taylor; T G Mainprize; J A Squire; J T Rutka
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

2.  Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomas.

Authors:  V G Gorgoulis; E N Koutroumbi; A Kotsinas; P Zacharatos; C Markopoulos; L Giannikos; V Kyriakou; Z Voulgaris; I Gogas; C Kittas
Journal:  Mol Med       Date:  1998-12       Impact factor: 6.354

Review 3.  Cancer stem cells and hepatocellular carcinoma.

Authors:  Zhixing Yao; Lopa Mishra
Journal:  Cancer Biol Ther       Date:  2009-09       Impact factor: 4.742

4.  Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression.

Authors:  V G Gorgoulis; P Zacharatos; A Kotsinas; T Liloglou; A Kyroudi; M Veslemes; A Rassidakis; T D Halazonetis; J K Field; C Kittas
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

5.  Loss of heterozygosity of CDKN2A (p16INK4a) and RB1 tumor suppressor genes in testicular germ cell tumors.

Authors:  Tomislav Vladusic; Reno Hrascan; Nives Pecina-Slaus; Ivana Vrhovac; Marija Gamulin; Jasna Franekic; Bozo Kruslin
Journal:  Radiol Oncol       Date:  2010-09-09       Impact factor: 2.991

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.